Clinical management issues in males with sex chromosomal mosaicism and discordant phenotype/sex chromosomal patterns.
The recent availability of Y DNA probes has made it possible to identify two forms of 46,XX male syndrome: Y DNA positive and Y DNA negative. The Y DNA positive male results from a X;Y translocation with a low recurrence risk; the Y DNA negative males are due to a mutation with a high recurrence risk. 46,XX males and mosaic forms are phenotypically indistinguishable. A review of the case histories for 11 individuals indicates that affected males have highly variable genital and nongenital phenotypes. Physical findings may be clearly apparent or nonexistent. With the exception of external genitalia, the basis for this variability is unknown. It may be related to differences in Y chromatin expression as the result of variable inactivation of the X chromosomes, or to the existence of minor deletions or point mutations secondary to an exchange of genetic material. Common and uncommon clinical problems in these individuals require evaluation and follow-up care that is provided through a cooperative, interdisciplinary approach.
Van Dyke
D C
DC
Department of Pediatrics, University of Iowa, Iowa City.
Hanson
J W
JW
Moore
J W
JW
Patil
S R
SR
Hawtrey
C E
CE
Hansen
J R
JR
D000293:Adolescent; D000328:Adult; D000368:Aged; D002675:Child, Preschool; D004247:DNA / Q000032:analysis; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D008297:Male; D009030:Mosaicism; D009154:Mutation; D010641:Phenotype; D012189:Retrospective Studies; D012729:Sex Chromosome Aberrations / Q000188:drug therapy / Q000473:pathology / Q000503:physiopathology; D013739:Testosterone / Q000627:therapeutic use; D014178:Translocation, Genetic; D014998:Y Chromosome
D013739:Testosterone; D004247:DNA